carnosus, ATCC 51365 0 5 0 5 34 S aureus, ATCC 25923 4 4 MIC was

carnosus, ATCC 51365 0.5 0.5 34 S. aureus, ATCC 25923 4 4 MIC was determined using a modification of the CLSI broth microdilution method. P128 was tested at 256 to 0.125 μg/mL. S. aureus ATCC 25923 and S. carnosus ATCC 51365 were used as control strains. MBC was determined following the CLSI procedure by plating 100 μL from the MIC, MIC × 2, MIC × 4, and MIC × 8 wells on LB agar, and incubating the plates overnight at 37°C. Strains 1-30 constitute a global panel of distinct clinical isolates Captisol price (MRSA, strains1-27; MSSA, strains 28-30) obtained from the Public Health

Research Institute (NJ, USA); strains 31 and 32 are USA500. P128 expression and purification P128 protein was cloned and expressed under the inducible T7 expression system in E. coli ER2566 strain. Details of cloning AZD4547 in vitro and design of the P128 clone-construct were reported previously (22). To generate a purified preparation of P128 for the studies reported in this work, expression of P128 protein in E. coli ER2566 was induced with 1 mM IPTG, at 37°C for 4 h. The induced cell pellet was lysed and the protein in the supernatant was subjected to 0-50% ammonium sulphate precipitation

using solid ammonium sulphate at 4°C. The precipitate was dialysed against 25 mM Tris HCl buffer pH 8.0, passed through an Liothyronine Sodium anion exchange column. The unbound fraction (flow through), containing P128 protein, was bound to a cation exchange column using 50 mM sodium acetate buffer at pH 6.0. The bound protein was eluted using a linear gradient of 0 to 0.5 M sodium chloride. Fractions containing P128 protein were extensively dialysed against saline and used for all the studies. MIC and MBC The MIC was determined using a modified Clinical and Laboratory Standards Institute (CLSI) broth microdilution procedure

[23]. Briefly, microtiter wells were pre-coated with 0.5% bovine serum albumin (BSA) to prevent nonspecific P128 adherence to the polystyrene plate, based on the method published for lysostaphin [24]. Two-fold dilutions of P128 were AZD5363 in vivo prepared in Mueller Hinton broth (MHB; Himedia) supplemented with 0.1% BSA (Sigma Aldrich), and 50 μL aliquots of the P128 dilutions (0.125-256 μg/mL) were added to the wells. Bacterial suspensions (0.5 McFarland standard) were diluted in MHB to achieve 1 × 106 colony-forming units (CFU) per mL. Then 50 μL aliquots of the cell suspension were added to wells containing P128. Plates were incubated under static conditions at 35°C for 18 h.

Comments are closed.